Press release from Artimplant´s Nominating Committee

In advance of Artimplant’s Annual Meeting of Stockholders on May 3, 2007, Artimplant’s Nominating Committee has decided to propose that Ingemar Kihlström, Lennart Ribohn and Dick Söderberg be re-elected as members of the Board of Directors. Birgit Stattin-Norinder declines re-election. The Nominating Committee has also decided to propose Anna Malm Bernsten, currently deputy board member, and Wenche Rolfsen as new members.

Wenche Rolfsen, 54, is Vice President, Phase I Europe, Quintiles and Managing Director of Quintiles AB a contract research organization with core business in clinical development of drugs. She has among others, Board assignments for Biovitrum AB and Uppsala University Holding AB.